RSS

Intellectual Property

Dr Nicholas Jones and Elizabeth Swan, patent attorneys at European intellectual firm Withers & Rogers, explain why pharma companies may be missing out on opportunities to repurpose existing drugs. Read more

, Opinion

The July/August issue of EPM magazine is available for download with all the regulars and features on legal — IP, sterilisation, ACHEMA review, excipients, personalised medicine plus a drug delivery supplement. Read more

Latest Issue

Kathryn Moon, Life Science Risk & Insurance specialist at UK broker Gallagher, looks at why it can be essential for businesses in the industry to have a robust insurance policy in place to protect it. Read more

Opinion

TxCell has exercised its exclusive option to in-license the intellectual property rights of one of its academic partners, the University of British Columbia (UBC), onto its HLA-A2 CAR-Treg programme. Read more

Technology

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has revealed its deep concern over the European Commission’s proposal to open the supplementary protection certificates (SPC) legislation to introduce a manufacturing waive Read more

News

According to some reports, China is going to increase the amount of patent protection on pharmaceuticals from 20 years to 25 years, in a bid to deflect the criticism from the US over intellectual property violations. Read more

News

Clinical-stage drug development company, Evgen Pharma, has been granted a key European patent ascribing intellectual property rights to the company for a method of stabilising sulforaphane, which is the basis of its lead product, SFX-01 Read more

Technology

The UK’s BioIndustry Association (BIA) has welcomed the announcement, made by the minister for intellectual property, Sam Gymiah MP, on World Intellectual Property (IP) day, that the UK has ratified the Unified Patent Court Agreement (UPCA). Read more

News

A surge in pharma and biotech patents in the UK, reported by the European Patent Office (EPO), may be a sign of growing investor confidence within these sectors, according to IP firm Marks & Clerk. Read more

News

Novarum, wholly owned subsidiary of BBI Solutions, has been secured a US patent for its smartphone diagnostic technology. Read more

Technology

In this article, Frances Salisbury (partner) and Adam Gregory (associate) — European Patent Attorneys in the Life Sciences team at Mewburn Ellis — discuss innovation and IP of CAR-T therapies in more detail. Read more

, Opinion

In this instalment, R&D software provider, IDBS evaluates data safety and cloud computing. Read more

Opinion

PatSnap, a provider of research and development (R&D) analytics, has launched an online learning hub that will provide users with free courses on intellectual property (IP), PatSnap Academy. Read more

Technology

Recently, there has been a shift within the pharmaceutical industry veering its R&D away from the traditional corporate campuses and moving them to new collaborative biotech clusters. Nick Sutcliffe, discusses the risks and opportunities of the trend Read more

Opinion

Global intellectual property analytics company, PatSnap, and a technology consulting and IP research firm that works with R&D companies, GreyB, have entered into a strategic partnership to streamline research and development (R&D) globally. Read more

News

Simon Portman, Marks & Clerk Solicitors, outlines the work the company does advising pharmaceutical companies on intellectual property issues Read more

Opinion

On trial: Overcoming Clinical Challenges in BRIC Markets, explores conducting clinical trials in the pharmaceutical markets of the BRIC nations: Brazil, Russia, India and China. Read more

News